Modular Solution for Cosmetics Compliance
Check the Conformity of your Formulas
Secure your regulatory documents for each zone
Optimize on-site risk management
Manage your Safety Data Sheets efficiently
Automate your regulatory monitoring
Ensure the traceability of your substances
Maintain good HSE risk management
Following the announcement by the MoEUCC, substances manufactured or imported into Turkey in quantities of at least one tonne per year must be subject to temporary or permanent registration with the KKS by 30 September 2026 at the latest.
Recevez une fois par mois les dernières actus réglementaires et conseils d’experts.
New restrictions under REACH will make tattoo inks safer by limiting hazardous substances. However, controversy arises over the ban on two commonly used pigments. Learn more about these regulations and their impact on the tattoo industry.
French companies have until 31st March 2022 to clear stocks of isopropanol-based hand sanitizers. Learn about compliance and regulations for hydroalcoholic gels in this blog.
Explore the European legal framework for PPE compliance, focusing on Regulation 2016/425. Understand the importance of CE marking and the classification of PPE into three categories based on risk levels. Learn about the necessary compliance procedures and manufacturer responsibilities.
Following the UK's regulatory changes post-Brexit, companies marketing biocidal products must re-submit certain applications by March 31 and June 29, 2021. Compliance requires providing original applications and updated data, ensuring alignment with both UK and EU regulations.
The new Chinese Cosmetic Regulations allow international "cruelty-free" brands to enter the Chinese market without animal testing, provided they meet specific conditions. France leads the EU in issuing necessary GMP certificates, facilitating smoother exports for French companies.
Explore the scenarios and processes UK companies must navigate to comply with UK REACH authorisation requirements post-Brexit. Understand the implications for substances listed in Annex XIV and the necessary steps for maintaining compliance in both the UK and EU markets.
